Cargando…

Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district

INTRODUCTION: Helicobacter pylori is an important medical pathogen present in more than half of the world’s population. Various treatment regimen are in use for the eradication of H. pylori, but due to the emergence of antibiotic resistance, its management is a big issue for clinicians. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Syed Fahim, Paracha, Sohail Aziz, Ullah, Waheed, Muhammad, Iqbal, Iqbal, Somaid, Gul, Aisha, Hussain, Mudassir, Ullah, Hafiz, Zaman, Sadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768595/
https://www.ncbi.nlm.nih.gov/pubmed/36582782
http://dx.doi.org/10.33393/dti.2022.2481
_version_ 1784854205089972224
author Shah, Syed Fahim
Paracha, Sohail Aziz
Ullah, Waheed
Muhammad, Iqbal
Iqbal, Somaid
Gul, Aisha
Hussain, Mudassir
Ullah, Hafiz
Zaman, Sadir
author_facet Shah, Syed Fahim
Paracha, Sohail Aziz
Ullah, Waheed
Muhammad, Iqbal
Iqbal, Somaid
Gul, Aisha
Hussain, Mudassir
Ullah, Hafiz
Zaman, Sadir
author_sort Shah, Syed Fahim
collection PubMed
description INTRODUCTION: Helicobacter pylori is an important medical pathogen present in more than half of the world’s population. Various treatment regimen are in use for the eradication of H. pylori, but due to the emergence of antibiotic resistance, its management is a big issue for clinicians. METHODS: In this study all suspected cases that had visited District Headquarters Hospital Kohat were considered for screening of H. pylori infections. Preliminary information about their age, gender, general health conditions, occupation, etc. was taken for consideration. After recording initial signs and symptoms, samples were considered for H. pylori detection using stool antigen test and endoscopy. Fourteen-day proton pump inhibitor base triple and quadruple therapy were administered to each patient. RESULTS: In total (n = 178), there were high numbers of positivity in patients aged below 30 years (82; 46.06%), most of whom belonged to rural areas. CONCLUSION: This study concludes that there were high numbers of positive patients aged below 30 years, and according to this study MEL (Metronidazole + Esomeprazole + Levofloxacin) is the most effective treatment regimen for the eradication of H. pylori.
format Online
Article
Text
id pubmed-9768595
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AboutScience
record_format MEDLINE/PubMed
spelling pubmed-97685952022-12-28 Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district Shah, Syed Fahim Paracha, Sohail Aziz Ullah, Waheed Muhammad, Iqbal Iqbal, Somaid Gul, Aisha Hussain, Mudassir Ullah, Hafiz Zaman, Sadir Drug Target Insights Original Research Article INTRODUCTION: Helicobacter pylori is an important medical pathogen present in more than half of the world’s population. Various treatment regimen are in use for the eradication of H. pylori, but due to the emergence of antibiotic resistance, its management is a big issue for clinicians. METHODS: In this study all suspected cases that had visited District Headquarters Hospital Kohat were considered for screening of H. pylori infections. Preliminary information about their age, gender, general health conditions, occupation, etc. was taken for consideration. After recording initial signs and symptoms, samples were considered for H. pylori detection using stool antigen test and endoscopy. Fourteen-day proton pump inhibitor base triple and quadruple therapy were administered to each patient. RESULTS: In total (n = 178), there were high numbers of positivity in patients aged below 30 years (82; 46.06%), most of whom belonged to rural areas. CONCLUSION: This study concludes that there were high numbers of positive patients aged below 30 years, and according to this study MEL (Metronidazole + Esomeprazole + Levofloxacin) is the most effective treatment regimen for the eradication of H. pylori. AboutScience 2022-12-19 /pmc/articles/PMC9768595/ /pubmed/36582782 http://dx.doi.org/10.33393/dti.2022.2481 Text en Copyright © 2022, The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/© 2022 The Authors. This article is published by AboutScience and licensed under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Commercial use is not permitted and is subject to Publisher’s permissions. Full information is available at www.aboutscience.eu
spellingShingle Original Research Article
Shah, Syed Fahim
Paracha, Sohail Aziz
Ullah, Waheed
Muhammad, Iqbal
Iqbal, Somaid
Gul, Aisha
Hussain, Mudassir
Ullah, Hafiz
Zaman, Sadir
Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
title Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
title_full Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
title_fullStr Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
title_full_unstemmed Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
title_short Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district
title_sort success of 14-day triple and quadruple therapy for the control of helicobacter pylori infections in kohat district
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768595/
https://www.ncbi.nlm.nih.gov/pubmed/36582782
http://dx.doi.org/10.33393/dti.2022.2481
work_keys_str_mv AT shahsyedfahim successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT parachasohailaziz successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT ullahwaheed successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT muhammadiqbal successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT iqbalsomaid successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT gulaisha successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT hussainmudassir successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT ullahhafiz successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict
AT zamansadir successof14daytripleandquadrupletherapyforthecontrolofhelicobacterpyloriinfectionsinkohatdistrict